Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation
Open Access
- 4 December 2021
- Vol. 11 (12), 1344
- https://doi.org/10.3390/life11121344
Abstract
Long-term survival after heart transplantation (HTX) is impacted by adverse effects of immunosuppressive pharmacotherapy, and post-transplant lung cancer is a common occurrence. This study aimed to examine the risk factors, treatment, and prognosis of patients with post-transplant lung cancer. We included 625 adult patients who received HTX at Heidelberg Heart Center between 1989 and 2018. Patients were stratified by diagnosis and staging of lung cancer after HTX. Analysis comprised donor and recipient characteristics, medications including immunosuppressive drugs, and survival after diagnosis of lung cancer. A total of 41 patients (6.6%) were diagnosed with lung cancer after HTX, 13 patients received curative care and 28 patients had palliative care. Mean time from HTX until diagnosis of lung cancer was 8.6 ± 4.0 years and 1.8 ± 2.7 years from diagnosis of lung cancer until last follow-up. Twenty-four patients (58.5%) were switched to an mTOR-inhibitor after diagnosis of lung cancer. Multivariate analysis showed recipient age (HR: 1.05; CI: 1.01–1.10; p = 0.02), COPD (HR: 3.72; CI: 1.88–7.37; p < 0.01), and history of smoking (HR: 20.39; CI: 2.73–152.13; p < 0.01) as risk factors for post-transplant lung cancer. Patients in stages I and II had a significantly better 1-year (100.0% versus 3.6%), 2-year (69.2% versus 0.0%), and 5-year survival (53.8% versus 0.0%) than patients in stages III and IV (p < 0.01). Given the poor prognosis of late-stage post-transplant lung cancer, routine reassessment of current smoking status, providing smoking cessation support, and intensified lung cancer screening in high-risk HTX recipients are advisable.Keywords
Funding Information
- German Heart Foundation/German Foundation of Heart Research (Rasmus Rivinius, Fabrice Darche and Rasmus Rivinius)
This publication has 42 references indexed in Scilit:
- Lung Cancer after Heart Transplantation: Results from a Large Multicenter RegistryAmerican Journal of Transplantation, 2011
- Malignancy after Heart Transplantation: Analysis of 24-Year Experience at a Single CenterJournal of Cardiac Surgery, 2009
- Long-term results of lung cancer after heart transplantation: Single center 20-year experienceLung Cancer, 2009
- Long-term Survival of Heart Transplant Recipients with Lung Cancer: The Role of Chest Computed Tomography ScreeningThe Thoracic and Cardiovascular Surgeon, 2007
- It Is Time To Stop Ignoring Malignancy In Heart Transplantation: A Call To ArmsThe Journal of Heart and Lung Transplantation, 2005
- Lung Cancer After Heart Transplantation: A 17-Year ExperienceThe Annals of Thoracic Surgery, 2005
- Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant RecipientsThe Annals of Thoracic Surgery, 2005
- Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progressionTransplantation, 2003
- CARCINOMA OF THE LUNG AFTER HEART TRANSPLANTATIONTransplantation, 1996
- Solid tumors after heart transplantation: Lethality of lung cancerThe Annals of Thoracic Surgery, 1995